financetom
Business
financetom
/
Business
/
Skillsoft Corp Fiscal Q3 Adjusted Net Loss Narrows, Revenue Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Skillsoft Corp Fiscal Q3 Adjusted Net Loss Narrows, Revenue Falls
Dec 10, 2024 2:03 PM

04:36 PM EST, 12/10/2024 (MT Newswires) -- Skillsoft Corp ( SKIL ) reported a fiscal Q3 adjusted net loss of $1.82 a share, compared with the loss of $2.82 a year earlier.

Three analysts surveyed by FactSet expected a normalized loss of $3.

Revenue in the three months ended Oct. 31 fell to $137.2 million from $138.9 million a year earlier.

One analyst polled by FactSet expected $137.2 million.

For the full year, the company raised its revenue forecast to between $520 million to $530 million compared with the previous outlook of $510 million to $525 million. Three analysts surveyed by FactSet expect $517.1 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Boeing Reportedly Close to Buying Back Spirit AeroSystems
Update: Market Chatter: Boeing Reportedly Close to Buying Back Spirit AeroSystems
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- (Adds deal details in fourth and sixth paragraph) Boeing ( BA ) is close to buying back its former subsidiary Spirit AeroSystems ( SPR ) following the struggling supplier's notable progress in separate talks with European rival Airbus, Reuters reported Thursday, citing people familiar with the matter. The company started discussions earlier this...
Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy
Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) said Friday that it has resubmitted its New Drug Application for sotagliflozin to supplement insulin therapy for persons with type 1 diabetes and chronic kidney disease, following multiple consultations with the US Food and Drug Administration. The application remains in filed status at the FDA and the company...
Therma Bright Completes Second, Final Tranche of Fully Subscribed Non-Brokered Private Placement
Therma Bright Completes Second, Final Tranche of Fully Subscribed Non-Brokered Private Placement
Jun 21, 2024
08:46 AM EDT, 06/21/2024 (MT Newswires) -- Therma Bright ( TBRIF ) , a developer and investment partner in various diagnostic and medical device technologies, said on Friday that it has completed the second and final tranche of its non-brokered private placement. In the final tranche, Therma issued about 14.6 million units at $0.01 apiece for $145,500. Together with the...
Update: Market Chatter: DOJ Drops Claim TikTok Misled Consumers on Data Security
Update: Market Chatter: DOJ Drops Claim TikTok Misled Consumers on Data Security
Jun 21, 2024
08:45 AM EDT, 06/21/2024 (MT Newswires) -- (Updates to add details.) The US Department of Justice is dropping one of its two proposed claims against TikTok, opting to focus on the privacy of children over allegations that the social-media platform misled consumers regarding their data security, Bloomberg reported Friday, citing people familiar with the matter. The department is planning to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved